))
VitaDAO is a community owned collective funding early stage longevity research, governed by $VITA
«
»
Metformin: A healthspan extending drug? | Conversation with Nir Barzilai on Metformin by VitaDAO
Manage episode 357537957 series 3456025
Sisällön tarjoaa VitaDAO. VitaDAO tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Dr. Nir Barzilai is the director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health’s (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging. He is the Ingeborg and Ira Leon Rennert Chair of Aging Research, professor in the Departments of Medicine and Genetics, and member of the Diabetes Research Center and of the Divisions of Endocrinology & Diabetes and Geriatrics.
Speakers: Nir Barzilai and Tim Peterson
Hosts: Max Unfried and Morten Scheibye-Knudsen
VitaDAO is the world’s first decentralized intellectual property collective, funding and commissioning research into human longevity 👉vitadao.com
35 jaksoa
Jaa
